0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letters to the Editor   |    
The Diagnostic and Pharmacological Variances of Bipolar Disorder Versus Attention-Deficit/Hyperactivity Disorder
D. HOWARD LYSNE; THOMAS PETERSON; KEITH ERICKSON; MICHAEL URIELL
Am J Psychiatry 2006;163:2196-2196.

To the Editor: The hypotheses by Dr. Wagner et al. regarding the ineffectiveness of oxcarbazepine in the article “A Double-Blind, Randomized, Placebo-Controlled Trial of Oxcarbazepine in the Treatment of Bipolar Disorder in Children and Adolescents” may need to be modified over time because of the nearly 50% of bipolar disorder I subjects comorbid for ADHD that continued taking stimulants during the study. This stimulant subgroup introduces an ambiguous diagnostic heterogeneity into the study that will hopefully be sorted out over time as ADHD symptoms become better realized as a persistently distinct disorder or as an unfolding aspect of a disorder that is inherently bipolar. The use of stimulants in this subgroup may ultimately be at pharmacological odds with the overall goal of mood stability in bipolar mania (such as the use of nortriptyline in bipolar depression). Even though a data analysis was done to adjust for diagnostic variance due to ADHD in the comparison of scores on the Young Mania Rating Scale-50% response rate (because nearly one-half of the 70+% ADHD subjects remained on stimulants), the potential for pharmacological variance exists. We are reminded of Dr. DelBello’s work associating stimulant treatment with a younger age of bipolar onset, indicating there is at least some link between stimulant use and bipolarity (1).

1.DelBello M, Soutollo C, Hendricks W, Niemeier R, McElroy S, Strakowski S: Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset. Bipolar Disord 2001; 3:53–57
 
+

References

1.DelBello M, Soutollo C, Hendricks W, Niemeier R, McElroy S, Strakowski S: Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset. Bipolar Disord 2001; 3:53–57
 
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 38.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 52.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 56.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 1.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 42.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles
Memantine: a review of possible uses in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry 2013;22(2):166-71.
Atomoxetine-induced mania-like symptoms in an adolescent patient. Actas Esp Psiquiatr 2013 Mar-Apr;41(2):137-8.